Login / Signup
Aimee Bruch
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Atopic Dermatitis
Placebo Controlled
Double Blind
Phase Iii
Top Venues
JMIR mHealth and uHealth
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Wanja Alexander Weigandt
,
Yannic Schardt
,
Aimee Bruch
,
Raphael M Herr
,
Matthias Goebeler
,
Johannes Benecke
,
Astrid Schmieder
Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.
JMIR mHealth and uHealth
11 (2023)
Wanja Alexander Weigandt
,
Yannic Schardt
,
Aimee Bruch
,
Raphael M Herr
,
Matthias Goebeler
,
Johannes Benecke
,
Astrid Schmieder
Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.
JMIR mHealth and uHealth
11 (2023)
Wanja Alexander Weigandt
,
Yannic Schardt
,
Aimee Bruch
,
Raphael M Herr
,
Matthias Goebeler
,
Johannes Benecke
,
Astrid Schmieder
Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.
JMIR mHealth and uHealth
11 (2023)
Wanja Alexander Weigandt
,
Yannic Schardt
,
Aimee Bruch
,
Raphael M Herr
,
Matthias Goebeler
,
Johannes Benecke
,
Astrid Schmieder
Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.
JMIR mHealth and uHealth
11 (2023)
Wanja Alexander Weigandt
,
Yannic Schardt
,
Aimee Bruch
,
Raphael M Herr
,
Matthias Goebeler
,
Johannes Benecke
,
Astrid Schmieder
Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.
JMIR mHealth and uHealth
11 (2023)